Experimental hyperhomocysteinemia disturbs bone metabolism in rats

References

• Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993; 94: 646–50
   PubMed Web of Science ®Google Scholar
• NIH: NIH Consensus Development Panel on Osteoporosis, Prevention, Diagnosis, and Therapy. J Am Med Assoc 2001; 285: 785–95
   PubMed Web of Science ®Google Scholar
• Boonen S., Autier P., Barette M., Vanderschueren D., Lips P., Haentjens P. Functional outcome and quality of life following hip fracture in elderly women: A prospective controlled study. Osteoporos Int 2004; 15: 87–94
   PubMed Web of Science ®Google Scholar
• Chapuy M. C., Arlot M. E., Duboeuf F., Brun J., Crouzet B., Arnaud S., et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637–42
   PubMed Web of Science ®Google Scholar
• Herrmann M., Widmann T., Herrmann W. Homocysteine: a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 2005; 43: 1111–17
   PubMed Web of Science ®Google Scholar
• Herrmann M., Taban‐Shomal O., Müller S., Gunter L., Hübner U., Böhm M., et al. Hyperhomocysteinemia: the biochemical link between a weak heart and brittle bones?. Clin Lab 2006; 52: 137–47
   PubMed Web of Science ®Google Scholar
• McLean R. R., Jacques P. F., Selhub J., Tucker K. L., Samelson E. J., Broe K. E., et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004; 350: 2042–9
   PubMed Web of Science ®Google Scholar
• van Meurs J. B., Dhonukshe‐Rutten R. A., Pluijm S. M., van Der Klift M., de Jonge R., Lindemans J., et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350: 2033–41
   PubMed Web of Science ®Google Scholar
• Dhonukshe‐Rutten R. A. M., Pluijm S. M. F., de Groot L. C. P. G. M., Lips P., Smit J. H., van Staveren W. A. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005; 20: 921–9
   PubMed Web of Science ®Google Scholar
• Masse P. G., Boskey A. L., Ziv I., Hauschka P., Donovan S. M., Howell D. S., et al. Chemical and biomechanical characterization of hyperhomocysteinemic bone disease in an animal model. BMC Musculoskelet Disord 2003; 4: 2
   PubMed Web of Science ®Google Scholar
• Herrmann M., Widmann T., Colaianni G., Colucci S., Zallone A., Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005; 51: 2348–53
   PubMed Web of Science ®Google Scholar
• Koh J. M., Lee Y. S., Kim Y. S., Kim D. J., Kim H. H., Park J. Y., et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006; 21: 1003–11
   PubMed Web of Science ®Google Scholar
• Tasatargil A., Sadan G., Karasu E., Ozdem S. Changes in atrium and thoracic aorta reactivity to adenosinergic and adrenergic agonists in experimental hyperhomocysteinemia. J Cardiovasc Pharmacol 2006; 47: 673–9
   PubMed Web of Science ®Google Scholar
• Durand P., Lussier‐Cacan S., Blache D. Acute methionine load‐induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage‐derived tissue factor activity in rats. FASEB J 1997; 11: 1157–68
   PubMed Web of Science ®Google Scholar
• Durand P., Fortin L. J., Lussier‐Cacan S., Davignon J., Blache D. Hyperhomocysteinemia induced by folic acid deficiency and methionine load‐applications of a modified HPLC method. Clin Chim Acta 1996; 252: 83–93
   PubMed Web of Science ®Google Scholar
• Ungvari Z., Pacher P., Rischak K., Szollar L., Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet‐induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1999; 19: 1899–904
   PubMed Web of Science ®Google Scholar
• Gorski J. P., Apone S., Shaffer K. A., Batchelder A., Jean W., Williams J. A., et al. Hypercalcemia during the osteogenic phase after rat marrow ablation coincides with increased bone resorption assessed by the NTx marker. Bone 2000; 27: 103–10
   PubMed Web of Science ®Google Scholar
• Neuman R. E., Logan M. A. The determination of hydroxyproline. J Biol Chem 1950; 184: 299–306
   PubMed Web of Science ®Google Scholar
• Elian K. M. Plasma homocysteine and vascular disease. McGill J Med 1996; 2: 107–12
   Google Scholar
• Herrmann M., Kraenzlin M., Pape G., Sand‐Hill M., Herrmann W. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri‐ and postmenopausal women. Clin Chem Lab Med 2005; 43: 1118–23
   PubMed Web of Science ®Google Scholar
• Golbahar J., Hamidi A., Aminzadeh M. A., Omrani G. R. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross‐sectional study. Bone 2004; 35: 760–5
   PubMed Web of Science ®Google Scholar
• Sato Y., Honda Y., Iwamoto J., Kanoko T., Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. J Am Med Assoc 2005; 293: 1082–8
   PubMed Web of Science ®Google Scholar
• Cagnacci A., Baldassari F., Rivolta G., Arangino S., Volpe A. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 2003; 33: 956–9
   PubMed Web of Science ®Google Scholar
• Delmas P. D. Biochemical markers of bone turnover in osteoporosis. Osteoporosis: etiology, diagnosis and management, V. L Riggs, L. J Metton. Raven Press, New York 1988; 297–316
   Google Scholar
• Miyao M., Morita H., Hosoi T., Kurihara H., Inoue S., Hoshino S., et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 2000; 66: 190–4
   PubMed Web of Science ®Google Scholar
• Bode M. K., Laitinen P., Risteli J., Uusimaa P., Juvonen T. Atherosclerosis, type 1 collagen cross‐linking and homocysteine. Atherosclerosis 2000; 152: 531–2
   PubMed Web of Science ®Google Scholar
• Lubec B., Fang‐Kircher S., Lubec T., Blom H. J., Boers G. H. Evidence for McKusick's hypothesis of deficient collagen cross‐linking in patients with homocystinuria. Biochim Biophys Acta 1996; 1315: 159–62
   PubMed Web of Science ®Google Scholar
• Sakamotoa W., Isomuraa H., Fujiea K., Deyamab Y., Katoc A., Nishihirad J., et al. Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3‐E1 preosteoblastic cells. Biochim Biophys Acta 2005; 1740: 12–16
   PubMed Web of Science ®Google Scholar
• Heritable disorders of connective tissue, V. A McKusick. C. V. Mosby, St. Louis, Mo. 1966
   Google Scholar
• Carmel R., Lau K. H., Baylink D. J., Saxena S., Singer F. R. Cobalamin and osteoblast‐specific proteins. N Engl J Med 1988; 319: 70–5
   PubMed Web of Science ®Google Scholar
• Kim G. S., Kim C. H., Park J. Y., Lee K. U., Park C. S. Effects of vitamin B‐12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 1996; 45: 1443–6
   PubMed Web of Science ®Google Scholar
• Iqbal M. P., Ahmet M., Umer M., Mehboobali N., Qureshi A. A. Effect of methotrexate and folinic acid on skeletal growth in mice. Acta Paediatr 2003; 92: 1438–44
   PubMed Web of Science ®Google Scholar
• McFarlane S. I., Muniyappa R., Shin J. J., Bahtiyar G., Sowers J. R. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?. Endocrine 2004; 23: 1–10
   PubMed Web of Science ®Google Scholar
• Herrmann M., Stanger O., Paulweber B., Hufnagl C., Herrmann W. Folate supplementation does not affect biochemical markers of bone turnover. Clin Lab 2006; 52: 131–6
   PubMed Web of Science ®Google Scholar
• Luckock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71: 121–38
   PubMed Web of Science ®Google Scholar